Cite
HARVARD Citation
Falcone, F. et al. (2019). Application of the Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) to patients conservatively treated: Outcomes from an institutional series. European journal of obstetrics, gynecology, and reproductive biology. pp. 220-225. [Online].